United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,803,200 | 1,279,700 | 1,557,100 | 1,340,100 | 1,593,100 |
| Marketable Securities | 859,100 | 874,000 | 1,363,200 | 1,427,500 | 1,455,600 |
| Receivables | 310,300 | 312,000 | 350,200 | 297,700 | 379,300 |
| Inventories | 193,800 | 178,300 | 183,100 | 176,500 | 169,200 |
| Other current assets | 317,300 | 228,000 | 248,900 | 252,200 | 229,700 |
| TOTAL | $3,483,700 | $2,872,000 | $3,702,500 | $3,494,000 | $3,826,900 |
| Non-Current Assets | |||||
| PPE Net | 1,930,100 | 1,840,700 | 1,729,700 | 1,555,600 | 1,362,400 |
| Investments And Advances | 1,141,100 | 1,317,400 | 1,776,700 | 1,567,300 | 1,917,700 |
| Other Non-Current Assets | 665,200 | 684,100 | 671,100 | 734,200 | 801,000 |
| TOTAL | $3,736,400 | $3,842,200 | $4,177,500 | $3,857,100 | $4,081,100 |
| Total Assets | $7,220,100 | $6,714,200 | $7,880,000 | $7,351,100 | $7,908,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 497,800 | 498,300 | 488,000 | 468,000 | 432,000 |
| Other current liabilities | 110,000 | 100,800 | 72,600 | 78,300 | 95,100 |
| TOTAL | $607,800 | $599,100 | $560,600 | $546,300 | $527,100 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 212,000 | 214,000 | 223,200 | 214,600 | 207,300 |
| TOTAL | $212,000 | $214,000 | $223,200 | $214,600 | $207,300 |
| Total Liabilities | $819,800 | $813,100 | $783,800 | $760,900 | $734,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,891 | 42,447 | 43,828 | 43,057 | 45,226 |
| Common Shares | 800 | 800 | 800 | 800 | 800 |
| Retained earnings | 9,164,800 | 8,831,800 | 8,556,900 | 8,192,600 | 7,853,900 |
| Other shareholders' equity | -16,100 | -9,800 | 500 | 100 | 500 |
| TOTAL | $6,400,300 | $5,901,100 | $7,096,200 | $6,590,200 | $7,173,600 |
| Total Liabilities And Equity | $7,220,100 | $6,714,200 | $7,880,000 | $7,351,100 | $7,908,000 |